170 related articles for article (PubMed ID: 9382951)
21. Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells.
Yu JS; Burwick JA; Dranoff G; Breakefield XO
Hum Gene Ther; 1997 Jun; 8(9):1065-72. PubMed ID: 9189764
[TBL] [Abstract][Full Text] [Related]
22. Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccine.
Thomas MC; Greten TF; Pardoll DM; Jaffee EM
Hum Gene Ther; 1998 Apr; 9(6):835-43. PubMed ID: 9581906
[TBL] [Abstract][Full Text] [Related]
23. Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF.
Aruga E; Aruga A; Arca MJ; Lee WM; Yang NS; Smith JW; Chang AE
Cancer Gene Ther; 1997; 4(3):157-66. PubMed ID: 9171934
[TBL] [Abstract][Full Text] [Related]
24. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
Ali SA; McLean CS; Boursnell ME; Martin G; Holmes CL; Reeder S; Entwisle C; Blakeley DM; Shields JG; Todryk S; Vile R; Robins RA; Rees RC
Cancer Res; 2000 Mar; 60(6):1663-70. PubMed ID: 10749137
[TBL] [Abstract][Full Text] [Related]
25. Genetically engineered tumor cell vaccine in a head and neck cancer model.
Couch M; Saunders JK; O'Malley BW; Pardoll D; Jaffee E
Laryngoscope; 2003 Mar; 113(3):552-6. PubMed ID: 12616213
[TBL] [Abstract][Full Text] [Related]
26. MCA106 fibrosarcoma cells transduced with granulocyte/macrophage colony-stimulating factor are not superior to the wild-type cells in suppressing the growth of hepatic metastases.
Dong XD; Abdel-Wahab Z; Dematos P; Fong T; Pruitt SK; Seigler HF
J Surg Oncol; 1999 May; 71(1):36-45. PubMed ID: 10362090
[TBL] [Abstract][Full Text] [Related]
27. Irradiated tumor cells adenovirally engineered to secrete granulocyte/macrophage-colony-stimulating factor establish antitumor immunity and eliminate pre-existing tumors in syngeneic mice.
Nagai E; Ogawa T; Kielian T; Ikubo A; Suzuki T
Cancer Immunol Immunother; 1998 Oct; 47(2):72-80. PubMed ID: 9769115
[TBL] [Abstract][Full Text] [Related]
28. In vivo responses to vaccination with Mage-b, GM-CSF and thioglycollate in a highly metastatic mouse breast tumor model, 4T1.
Gravekamp C; Leal B; Denny A; Bahar R; Lampkin S; Castro F; Kim SH; Moore D; Reddick R
Cancer Immunol Immunother; 2008 Jul; 57(7):1067-77. PubMed ID: 18094967
[TBL] [Abstract][Full Text] [Related]
29. Immunogenetic therapy of human melanoma utilizing autologous tumor cells transduced to secrete granulocyte-macrophage colony-stimulating factor.
Chang AE; Li Q; Bishop DK; Normolle DP; Redman BD; Nickoloff BJ
Hum Gene Ther; 2000 Apr; 11(6):839-50. PubMed ID: 10779161
[TBL] [Abstract][Full Text] [Related]
30. Dendritic cells genetically engineered to simultaneously express endogenous tumor antigen and granulocyte macrophage colony-stimulating factor elicit potent therapeutic antitumor immunity.
Nakamura M; Iwahashi M; Nakamori M; Ueda K; Matsuura I; Noguchi K; Yamaue H
Clin Cancer Res; 2002 Aug; 8(8):2742-9. PubMed ID: 12171908
[TBL] [Abstract][Full Text] [Related]
31. Flt3 ligand antitumor activity in a murine breast cancer model: a comparison with granulocyte-macrophage colony-stimulating factor and a potential mechanism of action.
Braun SE; Chen K; Blazar BR; Orchard PJ; Sledge G; Robertson MJ; Broxmeyer HE; Cornetta K
Hum Gene Ther; 1999 Sep; 10(13):2141-51. PubMed ID: 10498246
[TBL] [Abstract][Full Text] [Related]
32. Effects of irradiated tumor vaccine and infusion of granulocyte-macrophage colony-stimulating factor and interleukin-12 on established gliomas in rats.
Chen JC; Chen Y; Wu JM; Su YH; Tai KF; Tseng SH
Cancer Immunol Immunother; 2006 Jul; 55(7):873-83. PubMed ID: 16133106
[TBL] [Abstract][Full Text] [Related]
33. Properties of bcr-abl-transformed mouse 12B1 cells secreting interleukin-2 and granulocyte-macrophage colony stimulating factor (GM-CSF): II. Adverse effects of GM-CSF.
Petráčková M; Staněk L; Mandys V; Dundr P; Vonka V
Int J Oncol; 2012 Jun; 40(6):1915-22. PubMed ID: 22446515
[TBL] [Abstract][Full Text] [Related]
34. Vaccination with allogeneic GM-CSF gene-modified lung cancer cells: antitumor activity comparing with that induced by autologous vaccine.
Li H; Jiang HJ; Ma MQ; Wei F; An XM; Ren XB
Cancer Biother Radiopharm; 2007 Dec; 22(6):790-8. PubMed ID: 18158770
[TBL] [Abstract][Full Text] [Related]
35. Establishment and characterization of a rectal cancer model in mice: application to cytokine gene therapy.
Chen Y; Chang KJ; Hwang LH; Chen CN; Tseng SH
Int J Colorectal Dis; 2002 Nov; 17(6):388-95. PubMed ID: 12355214
[TBL] [Abstract][Full Text] [Related]
36. Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Yamaue H
Int J Oncol; 2007 Oct; 31(4):931-9. PubMed ID: 17786327
[TBL] [Abstract][Full Text] [Related]
37. Adenovirus-mediated combined P16 gene and GM-CSF gene therapy for the treatment of established tumor and induction of antitumor immunity.
Wang L; Qi X; Sun Y; Liang L; Ju D
Cancer Gene Ther; 2002 Oct; 9(10):819-24. PubMed ID: 12224022
[TBL] [Abstract][Full Text] [Related]
38. Vaccination with leukemia cells expressing cell-surface-associated GM-CSF blocks leukemia induction in immunocompetent mice.
Ling X; Wang Y; Dietrich MF; Andreeff M; Arlinghaus RB
Oncogene; 2006 Jul; 25(32):4483-90. PubMed ID: 16547503
[TBL] [Abstract][Full Text] [Related]
39. Synergy between dendritic cells and GM-CSF-secreting tumor cells for the treatment of a murine renal cell carcinoma.
Driessens G; Hoffmann P; Pouwels M; Zlotta A; Schulman C; Velu T; Bruyns CA
J Immunother; 2009; 32(2):140-4. PubMed ID: 19238012
[TBL] [Abstract][Full Text] [Related]
40. Immunomodulatory properties of antineoplastic drugs administered in conjunction with GM-CSF-secreting cancer cell vaccines.
Nigam A; Yacavone RF; Zahurak ML; Johns CM; Pardoll DM; Piantadosi S; Levitsky HI; Nelson WG
Int J Oncol; 1998 Jan; 12(1):161-70. PubMed ID: 9454900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]